A new paradigm in medicine. Unlocking intractable drug targets with exosites. OUR STORY ExoSightâ„¢: A comprehensive platform to expand the universe of druggable enzymes. EXOSITES Modulating enzyme activity in oncology and inflammation with precision and potency. PIPELINE Join us in charting new territory on our mission to develop breakthrough medicines. CAREERS recent news Exo announces lead program, targeting TANK Binding Kinase 1 (TBK1), for the treatment of autoimmune diseases&Appointment of Alexandra Joseph, PhD, as Executive Vice President of Biology READ MORE Exo Therapeutics Appoints Nagesh Mahanthappa as Executive Chair READ MORE